Paper92167
Procainamide-induced lupus erythematosus-like syndrome in relation to acetylator phenotype and plasma levels of procainamide.
Sonnhag C and 2 others. Acta Med Scand, 1979. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Procainamide-induced lupus erythematosus-like syndrome in relation to acetylator phenotype and plasma levels of procainamide. Papers, record 92167. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/92167
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Procainamide-induced lupus erythematosus-like syndrome in relation to acetylator phenotype and plasma levels of procainamide.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Isoniazid | Major topic |
| Lupus Erythematosus, Systemic | Major topic |
| Procainamide | Major topic |
| Acecainide | |
| Acetylation | |
| Adult | |
| Aged | |
| Antibodies, Antinuclear | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Phenotype | |
| Sulfapyridine |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38436771 | Mendelian randomization study on causal association of FAM210B with drug-induced lupus. | Clin Rheumatol | 2024 | https://conductscience.org/library/papers/38436771 | PubMed |
| 29870500 | Drug-induced lupus erythematosus: an update on drugs and mechanisms. | Curr Opin Rheumatol | 2018 | https://conductscience.org/library/papers/29870500 | PubMed |
| 15565348 | Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis. | Eur J Clin Pharmacol | 2005 | https://conductscience.org/library/papers/15565348 | PubMed |
| 9773259 | Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus. | Clin Rev Allergy Immunol | 1998 | https://conductscience.org/library/papers/9773259 | PubMed |
| 6198178 | Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamide. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6198178 | PubMed |
| 6138257 | Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6138257 | PubMed |
| 3758143 | Evaluation of once daily endralazine in hypertension. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3758143 | PubMed |
| 2859977 | Genetically determined variability in acetylation and oxidation. Therapeutic implications. | Drugs | 1985 | https://conductscience.org/library/papers/2859977 | PubMed |
| 1793523 | Drug-related lupus. Incidence, mechanisms and clinical implications. | Drug Saf | 1991 | https://conductscience.org/library/papers/1793523 | PubMed |
| 346289 | Clinical pharmacokinetics of procainamide. | Clin Pharmacokinet | 1978 | https://conductscience.org/library/papers/346289 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/92167
GET https://conductscience.org/api/papers/v1/92167/authors